Bagby Christina, Ronnett Brigitte M, Yemelyanova Anna, Maleki Zahra, Kuhn Elisabetta, Vang Russell
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Int J Gynecol Pathol. 2013 Sep;32(5):433-43. doi: 10.1097/PGP.0b013e31826a6446.
We report the clinicopathologic and immunohistochemical features in 8 patients with tubal or ovarian high-grade serous carcinoma that was present in uterine samples, in which there was the potential for clinical and morphologic misinterpretation as a primary uterine lesion before hysterectomy/bilateral salpingo-oophorectomy. Patients ranged in age from 45 to 70 yr (mean, 57 yr). The initial presentation was variable, ranging from incidental findings on routine Pap smears to pleural effusion. During the preoperative clinical investigation, 7 of 8 patients did not have evidence of an adnexal tumor based on physical examination and radiologic imaging, and serum CA-125 levels were normal to low in 4 of 5 patients. Six patients required multiple rounds of uterine samples, and the preoperative uterine specimens that contained lesional tissue and were available for rereview in all 8 patients included endometrial biopsies/curettages (n=6), endocervical curettages (n=3), Pap smears (n=2), and a hysteroscopic myomectomy specimen (n=1). The amount of carcinoma in these specimens was typically scanty. The lesions in most cases were characterized by detached and minute epithelial clusters, small papillae, and/or individual cells. The constituent glandular cells exhibited notable atypia. Psammoma bodies were identified in only 2 cases. Immunostains for WT-1 were positive in 3 of 4 preoperative specimens. All patients ultimately underwent a hysterectomy/bilateral salpingo-oophorectomy, which revealed an invasive high-grade serous carcinoma of tubal (n=6) or ovarian (n=2) origin. The mean/median tumor size was 3.2/1.7 cm. Transtubal spread was considered the most likely mechanism resulting in tubal/ovarian carcinoma being found in the preoperative uterine samples. These findings highlight the deceptive clinical features of some tubal/ovarian high-grade serous carcinomas, and demonstrate that small and clinically undetectable adnexal high-grade serous carcinomas can initially present in uterine biopsies/curettages. To guide clinical evaluation more accurately and prevent histologic misdiagnosis/misclassification, a possible adnexal origin should be considered in the differential diagnosis of small, detached, and markedly atypical glandular fragments in endometrial or cervical specimens, and immunohistochemical staining for WT-1 is recommended in this setting.
我们报告了8例输卵管或卵巢高级别浆液性癌患者的临床病理及免疫组化特征,这些癌存在于子宫样本中,在子宫切除/双侧输卵管卵巢切除术前,有可能被临床误诊为原发性子宫病变。患者年龄在45至70岁之间(平均57岁)。最初表现各异,从常规巴氏涂片偶然发现到胸腔积液。术前临床检查期间,8例患者中有7例根据体格检查和影像学检查未发现附件肿瘤证据,5例患者中有4例血清CA-125水平正常或偏低。6例患者需要多次获取子宫样本,所有8例患者术前含有病变组织且可供重新检查的子宫标本包括子宫内膜活检/刮宫(n = 6)、宫颈刮宫(n = 3)、巴氏涂片(n = 2)和宫腔镜下子宫肌瘤切除标本(n = 1)。这些标本中的癌组织通常很少。大多数病例中的病变特征为散在的微小上皮细胞簇、小乳头和/或单个细胞。组成腺细胞表现出明显的异型性。仅在2例中发现砂粒体。4例术前标本中有3例WT-1免疫染色呈阳性。所有患者最终均接受了子宫切除/双侧输卵管卵巢切除术,结果显示为输卵管(n = 6)或卵巢(n = 2)起源的浸润性高级别浆液性癌。肿瘤平均/中位数大小为3.2/1.7 cm。经输卵管播散被认为是术前子宫样本中发现输卵管/卵巢癌的最可能机制。这些发现突出了一些输卵管/卵巢高级别浆液性癌具有欺骗性的临床特征,并表明临床上难以检测到的小附件高级别浆液性癌最初可能出现在子宫内膜活检/刮宫标本中。为了更准确地指导临床评估并防止组织学误诊/错误分类,在鉴别诊断子宫内膜或宫颈标本中微小、散在且明显异型的腺性碎片时,应考虑可能的附件起源,在此情况下建议进行WT-1免疫组化染色。